Sugi Predict

Sugi Predict / Compounds / SCHEMBL4173829

SCHEMBL4173829

SCHEMBL4173829

Cc1cc(Nc2cncc(Nc3ccc(C#N)c(NC4CCCC4)c3)n2)n[nH]1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ JAK3 P52333 6/20 0.41
▸ JAK2 O60674 4/20 0.41
▸ KCNH2 Q12809 2/20 0.41
▸ LRRK2 Q5S007 1/20 0.39
▸ CDK2 P24941 3/20 0.39
▸ CSNK2A2 P19784 2/20 0.39
▸ CSNK2A1 P68400 2/20 0.39
▸ HIPK2 Q9H2X6 2/20 0.39
▸ DYRK3 O43781 1/20 0.39
▸ GSK3B P49841 1/20 0.39
▸ CSNK2B P67870 1/20 0.39
▸ PIM3 Q86V86 1/20 0.39
▸ AURKA O14965 2/20 0.38
▸ FER P16591 1/20 0.38
▸ NTRK1 P04629 2/20 0.37
▸ MUSK O15146 1/20 0.37
▸ LCK P06239 1/20 0.37
▸ RET P07949 1/20 0.37
▸ FGFR3 P22607 1/20 0.37
▸ CCNE1 P24864 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4178647 0.87 JAK2 (0.44) JAK3JAK2KCNH2LRRK2AURKA
SCHEMBL13663528 0.85 PLK4 (0.44) JAK3JAK2LRRK2AURKANTRK1
SCHEMBL4017479 0.80 AURKA (0.42) JAK3JAK2CDK2AURKANTRK1
SCHEMBL4175007 0.78 JAK3 (0.49) JAK3JAK2LRRK2CDK2TYK2
SCHEMBL4183689 0.78 IDO1 (0.55) JAK3JAK2CDK2AURKANTRK1
SCHEMBL4176790 0.76 AURKA (0.56) JAK3JAK2CDK2AURKANTRK1
SCHEMBL4176741 0.74 AURKA (0.49) JAK3JAK2LRRK2CSNK2A2CSNK2A1
SCHEMBL4162147 0.73 ABCG2 (0.48) JAK3JAK2AURKANTRK1AURKB
SCHEMBL13663483 0.73 JAK2 (0.47) JAK3JAK2AURKAAURKB
SCHEMBL4177008 0.73 RAB9A (0.46) AURKAAURKB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090270418-A1 PYRAZOLE PYRAZINE AMINE COMPOUNDS AS KINASE INHIBITORS, COMPOSITIONS THEREOF AND METHODS OF TREATMENT THEREWITH SIGNAL PHARMACEUTICALS, LLC 2009-10-29 — — US claimed
WO-2009089042-A1 PYRAZOLE PYRAZINE AMINE COMPOUNDS AS KINASE INHIBITORS, COMPOSITIONS THEREOF AND METHODS OF TREATMENT THEREWITH SIGNAL PHARMACEUTICALS, LLC (US) 2009-07-16 — — WO claimed
US-20090270418-A1 PYRAZOLE PYRAZINE AMINE COMPOUNDS AS KINASE INHIBITORS, COMPOSITIONS THEREOF AND METHODS OF TREATMENT THEREWITH SIGNAL PHARMACEUTICALS, LLC 2009-10-29 — — US disclosed
US-20090270418-A1 PYRAZOLE PYRAZINE AMINE COMPOUNDS AS KINASE INHIBITORS, COMPOSITIONS THEREOF AND METHODS OF TREATMENT THEREWITH SIGNAL PHARMACEUTICALS, LLC 2009-10-29 — — US disclosed
US-20090270418-A1 PYRAZOLE PYRAZINE AMINE COMPOUNDS AS KINASE INHIBITORS, COMPOSITIONS THEREOF AND METHODS OF TREATMENT THEREWITH SIGNAL PHARMACEUTICALS, LLC 2009-10-29 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090270418-A1 PYRAZOLE PYRAZINE AMINE COMPOUNDS AS KINASE INHIBITORS, COMPOSITIONS THEREOF AND METHODS OF TREATMENT THEREWITH MAP3K1, MAP3K15, MAP3K5 JAK3 35/4885JAK2 39/4885KCNH2 2580/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.